Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.Health effect - clinical code :e233001 health effect - clinical code :e010901 health effect - clinical code :e060101.
|
During a review of an article titled "complete heart block and ventricular asystole caused by vagus nerve stimulation therapy" an event involving a vns patient experiencing bradycardia and complete atrioventricular node block in association with vns stimulation was reported in an unknown vns patient.The patient was hospitalized due to this arrhythmia, dyspnea and dizziness.The patient also reported pain at their chest.The vns was disabled and the bradycardia was noted to be resolved.The patient also reported an increase in seizures after this settings adjustment.The article was unable to identify the exact mechanism of the reported bradyarrhythmia.The patient nor healthcare professionals involved were not identified, making follow up on this event impossible no other relevant information has been received to date.
|